A combined strategy of conventional cytogenetics, fluorescent in situ hybridization and microsatellite polymerase chain reaction to analyze the deletion of chromosome 6 in laryngeal squamous cell carcinoma

Oncology Reports

Volumn 18, Issue 6, 2007, Pages 1379-1385

  Kang, Ning ^a,b   Li, Fucai ^a   Fu, Weineng ^a   Zhang, Jinghai ^b   Sun, Kailai ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Conventional cytogenetics; Fluorescent in situ hybridization; Laryngeal squamous cell carcinoma; Loss of heterozygosity; Microsatellite instability

Indexed keywords

MICROSATELLITE DNA;

ARTICLE; CANCER STAGING; CELL DIFFERENTIATION; CHROMOSOME 6; CHROMOSOME DELETION; CHROMOSOME PAINTING; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; HUMAN; KARYOTYPING; LARYNX TUMOR; MALE; METHODOLOGY; PATHOLOGY; POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CHROMOSOME DELETION; CHROMOSOME PAINTING; CHROMOSOMES, HUMAN, PAIR 6; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LARYNGEAL NEOPLASMS; MALE; MICROSATELLITE REPEATS; NEOPLASM STAGING; POLYMERASE CHAIN REACTION;

EID: 38449117790     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.18.6.1379     Document Type: Article

References (43)

1. Schuller DE, Ozer E, Agrawal A, Grecula JC, Rhoades CA and Young DC: Multimodal intensification regimens for advanced, resectable, previously untreated squamous cell cancer of the oral cavity, oropharynx, or hypopharynx: a 12-year experience. Arch Otolaryngol Head Neck Surg 133: 320-326, 2007. (Pubitemid 46631582)
2. Rafferty MA, Fenton JE and Jones AS: The history, aetiology and epidemiology of laryngeal carcinoma. Clin Otolaryngol Allied Sci 26: 442-446, 2001. (Pubitemid 34088245)
3. Fei SZ: Epidemic feature of laryng carcinoma. In: Oncology of Head and Neck. 1st edition. Publisher of Tianjin Science and Technology, Tianjin, pp659-660, 1993.
4. Nowell PC and Hungerford DA: A minute chromosome in human chronic granulocytic leukemia. Science 132: 1497, 1960.
5. Batanian JR, Slovak ML, Mohamed A, Dobin S, Luthardt FW and Keitges EA: Trisomy 15 is frequently observed as a minor clone in patients with Anemia/MDS/NHL and as a major clone in patients with AML. Cancer Genet Cytogenet 121: 186-189, 2000.
6. Hayne CC, Winer E, Williams T, Chaves F, Khorsand J and Mark HFL: Acute lymphoblastic leukemia with 4;11 translocation analyzed by a multi-modal strategy of conventional cytogenetics, FISH, morphology, flow cytometry and molecular genetics, and review of the literature. Exp Mol Pathol 81: 62-71, 2006. (Pubitemid 43946859)
7. Jarmuz M, Golusinski W, Grenman R and Szyfter K: Analysis of chromosome aberrations in cell lines derived from laryngeal cancer in relation to tumor progression. Eur Arch Otorhinolaryngol 259: 269-273, 2002. (Pubitemid 34591725)
8. Cossman J: Molecular genetics in cancer diagnosis. Elsevier, New York, Amsterdam, London, 1990.
9. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, Corio R, Lee D, Greenberg B, Koch W and Sidransky D: Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 56: 2488-2492, 1996. (Pubitemid 26170679)
10. Mark HF, Gnepp DR, Nigri P, Campbell W and Mark Y: Combined strategy of conventional cytogenetics, fluorescent in situ hybridization and chromosome morphometry for analysis of parotid gland tumor. Ann Clin Lab Sci 24: 555-559, 1994. (Pubitemid 24332455)
11. Szuhai K, Ijszenga M, Tanke HJ, Taminiau AHM, De Schepper A, van Duinen SG, Rosenberg C and Hogendoorn PCW: Detection and molecular cytogenetic characterization of a novel ring chromosome in a histological variant of Ewing sarcoma. Cancer Genet Cytogenet 172: 12-22, 2007. (Pubitemid 44908688)
12. Hazelbag HM, Szuhai K, Tanke HJ, Rosenberg C and Hogendoorn PCW: Primary synovial sarcoma of the heart: a cytogenetic and molecular genetic analysis combining RT-PCR and COBRA-FISH of a case with a complex karyotype. Mod Pathol 17: 1434-1439, 2004. (Pubitemid 39473000)
13. Jin C, Jin Y, Wennerberg J, Dictor M and Mertens F: Nonrandom pattern of cytogenetic abnormalities in squamous cell carcinoma of the larynx. Genes Chromosomes Cancer 28: 66-76, 2000. (Pubitemid 30176764)
14. Dasgupta S, Mukherjee N, Roy S, Roy A, Sengupta A, Roychowdhury S and Panda CK: Mapping of the candidate tumor suppressor genes' loci on human chromosome 3 in head and neck squamous cell carcinoma of Indian patient population. Oral Oncol 38: 6-15, 2002. (Pubitemid 34076567)
15. Pandis N, Helm S, Bardi G, Flodrus U-M, Willn H, Mandahl N and Mitelman F: Chromosome analysis of 96 uterine leiomyomas. Cancer Genet Cytogenet 55: 11-18, 1991.
16. Shaffer LG and Tommerup N: ISCN: an international system for human cytogenetic nomenclature. Karger S (ed). Basel, 2005.
17. Wu HK, Kitamura K, Xi YR, Wang YT, Liu SL and Zhou DB: Cytogenetic analysis of bone marrow from patients with primary myelodysplastic syndrome. J Int Med Res 20: 254-266, 1992.
18. Sambrook J, Fritsch EF and Maniatis T: Molecular cloning: a laboratory manual. 3rd edition. Cold Spring Harbor Laboratory, New York, 2000.
19. Jang SJ, Chiba I, Hirai A, Hong WK and Mao L: Multiple oral squamous epithelial lesions: are they genetically related? Oncogene 20: 2235-2242, 2001. (Pubitemid 32531281)
20. Jin Y, Mandant N, Heim S, Biörklund A, Wennerberg J and Mitelman F: Unique karyotypic abnormalities in a squamous cell carcinoma of the larynx. Cancer Genet Cytogenet 30: 177-179, 1988. (Pubitemid 18033805)
21. Jin Y, Heim S, Mandahl N, Biörklund A, Wennerberg J and Mitelman F: Multiple clonal chromosome aberrations in squamous cell carcinomas of the larynx. Cancer Genet Cytogenet 44: 209-216, 1990. (Pubitemid 20051996)
22. Allegra E, Garozzo A, Grillo A and Catalano GB: Cytogenetic alterations in laryngeal carcinomas. Arch Otolaryngol Head Neck Surg 118: 1320-1322, 1992.
23. Shang CH, Fu WN, Xu ZHM, Li FC, Huang DF and Sun KL: Comparative genomic hybridization analysis of laryngeal carcinoma. Acta Genetica Sinica 31: 539-544, 2004. (Pubitemid 38788505)
24. Han RZH, Li XD, Guo YL, Zhang HY, Xiao SH, Liu QZH and Li P: Chromosomal analysis of human squamous cell carcinoma of the larynx. J Harbin Med Uni 28: 298-300, 1994.
25. Bockmuhl U, Wolf G, Schmidt S, Schwendel A, Jahnke V, Dietel M and Petersen I: Genomic alterations associated with malignancy in head and neck cancer. Head Neck 20: 145-151, 1998. (Pubitemid 28106227)
26. Bockmuhl U, Schmidt S, Petersen S and Petersen I: Deletion of chromosome 10q - a marker for metastasis of head-neck carcinomas? Laryngorhinootologie 79: 81-85, 2000. (Pubitemid 30141028)
27. Sun M, Srikantan V, Ma L, Li J, Zhang W, Petrovics G, Makarem M, Strovel JW, Horrigan SG, Augustus M, Sesterhenn IA, Moul JW, Chandrasekharappa S, Zou Z and Srivastava S: Characterization of frequently deleted 6q locus in prostate cancer. DNA Cell Biol 25: 597-607, 2006. (Pubitemid 44877512)
28. Chappell SA, Walsh T, Walker RA and Shaw JA: Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor gene correlates with poor differentiation in early breast carcinomas. Br J Cancer 76: 1558-1561, 1997. (Pubitemid 27520581)
29. Hoglund M, Gisselsson D, Hansen GB, Sall T and Mitelman F: Ovarian carcinoma develops through multiple modes of chromosomal evolution. Cancer Res 63: 3378-3385, 2003. (Pubitemid 36735898)
30. Casorzo L, Luzzi C, Nardacchione A, Picciotto F, Pisacane A and Risio M: Fluorescence in situ hybridization (FISH) evaluation of chromosomes 6, 7, 9 and 10 throughout human melanocytic tumorigenesis. Melanoma Res 15: 155-160, 2005. (Pubitemid 40839462)
31. Byrd JC, Devi GR, De Sorza AT, Jirtle RL and MacDonald RG: Disruption of ligand binding to the insulin-like growth factor II/mannose 6-phosphate receptor by cancer-associated missense mutations. J Biol Chem 274: 24408-24416, 1999.
32. Kishimoto Y, Morisawa T, Kitano M, Shiota G, Horie Y, Suou T, Ito H, Kawasaki H and Hasegawa J: Loss of heterozygosity of the mannose 6-phosphate/insulin-like growth factor II receptor and p53 genes in human hepatocellular carcinoma. Hepatol Res 20: 68-83, 2001. (Pubitemid 32294096)
33. Piao Z, Choi Y, Park C, Lee WJ, Park JH and Kim H: Deletion of the M6P/IGF2R gene in primary hepatocellular carcinoma. Cancer Lett 120: 39-43, 1997. (Pubitemid 27483309)
34. Hankins GR, De Souza AT, Bentley RC, Patel MR, Marks JR, Iglehart JD and Jirtle RL: M6P/IGF2 receptor: a candidate breast tumor suppressor gene. Oncogene 12: 2003-2009, 1996. (Pubitemid 26154672)
35. Huang Z, Wen Y, Shandilya R, Marks JR, Berchuck A and Murphy SK: High throughput detection of M6P/IGF2R intronic hypermethylation and LOH in ovarian cancer. Nucleic Acids Res 34: 555-563, 2006. (Pubitemid 43240243)
36. Hu CK, McCall S, Madden J, Huang H, Clough R, Jirtle RL and Anscher MS: Loss of heterozygosity of M6P/IGF2R gene is an early event in the development of prostate cancer. Prostate Cancer Prostatic Dis 9: 62-67, 2006. (Pubitemid 43378872)
37. Kong FM, Anscher MS, Washington MK, Killian JK and Jirtle RL: M6P/IGF2R is mutated in squamous cell carcinoma of the lung. Oncogene 19: 1572-1578, 2000. (Pubitemid 30175679)
38. Souza RF, Appel R, Yin J, Wang S, Smolinski KN, Abraham JM, Zou T-T, Shi Y-Q, Lei J, Cottrell J, Cymes K, Biden K, Simms L, Leggett B, Lynch PM, Frazier M, Powell SM, Harpaz N, Sugimura H, Young J and Meltzer SJ: Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours. Nat Genet 14: 255-257, 1996.
39. Ouyang H, Shiwaku HO, Hagiwara H, Miura K, Abe T, Kato Y, Ohtani H, Shiiba K, Souza RF, Meltzer SJ and Horii A: The insulin-like growth factor II receptor gene is mutated in genetically unstable cancers of the endometrium, stomach, and colorectum. Cancer Res 57: 1851-1854, 1997. (Pubitemid 27209709)
40. Qiu GB, Qiu GR, Xu ZHM, Huang DF, Gong LG, Li CY, Sun XH and Sun KL: Cloning and characterization of MTLC, a novel gene in 6q25. Chin J Med Genet 20: 94-97, 2003. (Pubitemid 36427795)
41. Qiu GB, Hao DM, Gong LG, Zhu ZY and Sun KL: MTLC gene was down-regulated in laryngeal cancer tissues and could promote apoptosis of Hep2 cell. Chin J Lab Med 28: 1178-1180, 2005.
42. Popescu NC, Zimonjic D and DiPaolo JA: Viral integration, fragile sites, and proto-oncogenes in human neoplasia. Hum Genet 84: 383-386, 1990. (Pubitemid 20129478)
43. Van Dyke DL, Worsham MJ, Benninger MS, Krause CJ, Baker SR, Wolf GT, Drumheller T, Tilley BC and Carey TE: Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region. Genes Chromosomes Cancer 9: 192-206, 1994. (Pubitemid 24074737)